Trials / Completed
CompletedNCT04609852
A Study to Assess the Safety and Tolerability of E8001 in Healthy Male Participants
A Randomized, Single-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of E8001 in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Eisai Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of E8001 of single ascending dose intravenous infusions in healthy male participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | E8001 | Intravenous infusion. |
| DRUG | Placebo | Intravenous infusion. |
Timeline
- Start date
- 2020-10-28
- Primary completion
- 2023-08-18
- Completion
- 2023-08-18
- First posted
- 2020-10-30
- Last updated
- 2023-09-25
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04609852. Inclusion in this directory is not an endorsement.